*Evaluation of biomarkers in VTE study with capillary blood sample; the EVA-II study*

Recruiting

• Conditions: pulmonary embolism; venous thrombosis; 10014523

• Registration Number: NL-OMON55145
• Lead Sponsor: Jeroen Bosch Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

-Patients with suspected Venous ThromboEmbolism, in whom the GP orders a
D-dimer test
-Life expectancy more than 3 months

Exclusion Criteria

Exclusion criteria are age below 18; anticoagulant treatment (vitamin K, NOAC,
low molecular-weight heparin) for other causes than VTE; pregnancy or a life
expectancy less than three months. Unwilling to participate in this study.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>D-dimer result</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Clinical outcom of VTE diagnosis</p><br>